OPTISCAN IMAGING LIMITED - Announcements

3.16%

9.2¢

Market Cap $76.85M

Healthcare Medical Devices

Optiscan Imaging Limited is an Australia-based company, which is engaged in the... Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Company’s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.More

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

OIL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/25	351.25KB	Share
OIL	Optiscan Initiates Breast Cancer Study in Melbourne	PRICE SENSITIVE	30/06/25	209.68KB	Share
OIL	Optiscan Signs Agreement with Long Grove Pharmaceuticals	PRICE SENSITIVE	23/06/25	181.14KB	Share
OIL	Optiscan Reveals InSpecta Device for Veterinary Medicine	PRICE SENSITIVE	10/06/25	214.9KB	Share
OIL	Optiscan Completes Cloud-based Telepathology Software MVP	PRICE SENSITIVE	27/05/25	148.85KB	Share
OIL	Robotic Surgery Collaboration with Mayo Clinic Progresses	PRICE SENSITIVE	13/05/25	161.82KB	Share
OIL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/25	458.42KB	Share
OIL	Appendix 4D	PRICE SENSITIVE	27/02/25	138.81KB	Share
OIL	Optiscan Reveals InForm Imaging Device for Pathology	PRICE SENSITIVE	19/02/25	211.17KB	Share
OIL	Optiscan Initiates GI Study in Germany with First Prototype	PRICE SENSITIVE	03/02/25	99.68KB	Share
OIL	OIL December 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/25	280.77KB	Share
OIL	Optiscan receives $1.775m R&D Tax Refund	PRICE SENSITIVE	31/01/25	68KB	Share
OIL	OIL Managing Director's Presentation & Chair's Address	PRICE SENSITIVE	21/11/24	2.72MB	Share
OIL	Optiscan Signs Research Agreement with Minnesota Vet College	PRICE SENSITIVE	18/11/24	77.16KB	Share
OIL	Optiscan Signs Agreement with Monash to Progress GI Scope	PRICE SENSITIVE	04/11/24	77.76KB	Share
OIL	OIL September 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/24	279.3KB	Share
OIL	Appendix 4E Preliminary Final Report	PRICE SENSITIVE	30/08/24	89.32KB	Share
OIL	Optiscan Signs MOU with University of Minnesota	PRICE SENSITIVE	19/08/24	102.17KB	Share
OIL	OIL June 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/07/24	316.61KB	Share
OIL	Optiscan Delivers Major Milestone in Telepathology Platform	PRICE SENSITIVE	29/07/24	73.64KB	Share
OIL	Optiscan Receives Ethical Clearance for Breast Cancer Study	PRICE SENSITIVE	15/07/24	401.21KB	Share
OIL	Optiscan 2024 Roadshow Presentation	PRICE SENSITIVE	01/07/24	2.44MB	Share
OIL	Optiscan Reveals InVue Imaging Device for Precision Surgery	PRICE SENSITIVE	04/06/24	172.87KB	Share
OIL	Optiscan Webinar Investor Presentation	PRICE SENSITIVE	16/05/24	1.95MB	Share
OIL	Optiscan Signs Know-How Agreement with Mayo Clinic	PRICE SENSITIVE	13/05/24	126.86KB	Share
OIL	OIL March 2024 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/24	277.05KB	Share
OIL	Optiscan appoints US Clinical & Regulatory Heads	PRICE SENSITIVE	02/04/24	114.29KB	Share
OIL	OIL Appendix 4D and 31 December 2023 Half-year report	PRICE SENSITIVE	23/02/24	1.6MB	Share
OIL	Optiscan receives $3 million CRC-P Industry Grant	PRICE SENSITIVE	13/02/24	114.39KB	Share
OIL	OIL December 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/24	324.61KB	Share
OIL	OIL Managing Director's Presentation & Chair's Address	PRICE SENSITIVE	23/11/23	2.88MB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	14/11/23	223.26KB	Share
OIL	OIL September 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/23	323.62KB	Share
OIL	Optiscan Correlates with Histology in Breast Study	PRICE SENSITIVE	19/09/23	102.36KB	Share
OIL	OIL Appendix 4E and June 2023 Annual Report	PRICE SENSITIVE	31/08/23	1.69MB	Share
OIL	Optiscan Achieves Telepathology Milestone	PRICE SENSITIVE	15/08/23	106.06KB	Share
OIL	OIL June 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	28/07/23	326.14KB	Share
OIL	Entitlement Offer Results and Shortfall Announcement	PRICE SENSITIVE	12/07/23	91.36KB	Share
OIL	Optiscan Entitlement Issue Prospectus	PRICE SENSITIVE	30/05/23	636.42KB	Share
OIL	Optiscan Launches Entitlement Offer to Raise $16.7M	PRICE SENSITIVE	30/05/23	134.45KB	Share
OIL	Trading Halt	PRICE SENSITIVE	26/05/23	183.4KB	Share
OIL	OIL March 2023 Quarterly Report and Appendix 4C	PRICE SENSITIVE	28/04/23	293.18KB	Share
OIL	Optiscan Platform Highly Accurate for Oral Cancer Diagnosis	PRICE SENSITIVE	14/03/23	108.11KB	Share
OIL	Optiscan Intends to pursue De Novo Pathway for InVivage	PRICE SENSITIVE	02/03/23	97.89KB	Share
OIL	OIL Appendix 4D and 31 December 2022 Half-year report	PRICE SENSITIVE	27/02/23	1.65MB	Share
OIL	Optiscan partners with Prolucid to develop AI Algorithms	PRICE SENSITIVE	30/01/23	99.21KB	Share
OIL	OIL December 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	27/01/23	402.35KB	Share
OIL	Optiscan Managing Director 2022 AGM Presentation	PRICE SENSITIVE	24/11/22	6.77MB	Share
OIL	OIL September 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/10/22	407.08KB	Share
OIL	Optiscan Imaging Acquires Intellectual Property	PRICE SENSITIVE	25/10/22	195.68KB	Share
OIL	Appendix 4E and 2022 Annual Report	PRICE SENSITIVE	31/08/22	1.08MB	Share
OIL	Optiscan Submits FDA 510(k) Application for InVivage Device	PRICE SENSITIVE	22/08/22	189.3KB	Share
OIL	OIL June 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/07/22	422.39KB	Share
OIL	Strategic Distribution Partnership - Additional Information	PRICE SENSITIVE	28/06/22	183.5KB	Share
OIL	Optiscan announces Strategic Distribution Partner for China	PRICE SENSITIVE	27/06/22	187.04KB	Share
OIL	OIL March 2022 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/04/22	388.88KB	Share
OIL	Appendix 4D and 31 December 2021 Half-year report	PRICE SENSITIVE	24/02/22	606.54KB	Share
OIL	OIL December 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/01/22	398.39KB	Share
OIL	2021 AGM Chairman's Address and MD Presentation	PRICE SENSITIVE	20/01/22	3.32MB	Share
OIL	Change of Managing Director	PRICE SENSITIVE	13/12/21	202.2KB	Share
OIL	Completion of imaging for Melbourne Breast cancer trial	PRICE SENSITIVE	12/11/21	162.56KB	Share
OIL	OIL September 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	27/10/21	398.13KB	Share
OIL	Receipt of R&D Tax Incentive Rebate	PRICE SENSITIVE	25/10/21	142.02KB	Share
OIL	OIL FY21 Annual Results Presentation	PRICE SENSITIVE	30/08/21	1MB	Share
OIL	Appendix 4E and 2021 Annual Report	PRICE SENSITIVE	30/08/21	1.35MB	Share
OIL	OIL June 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/07/21	417.64KB	Share
OIL	Update on seeking United States FDA approval & market entry	PRICE SENSITIVE	01/06/21	160.88KB	Share
OIL	OIL March 2021 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/04/21	395.38KB	Share
OIL	Appointment of New Non-executive Chair	PRICE SENSITIVE	19/04/21	208.78KB	Share
OIL	Appendix 4D and Financial Statements - 31 December 2020	PRICE SENSITIVE	25/02/21	1.13MB	Share
OIL	OIL breast cancer study to commence next stage - revised	PRICE SENSITIVE	08/02/21	199.92KB	Share
OIL	Optiscan breast cancer study to commence next stage	PRICE SENSITIVE	08/02/21	199.91KB	Share
OIL	OIL December 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	29/01/21	408.83KB	Share
OIL	Carl Zeiss Meditec AG Product Orders	PRICE SENSITIVE	13/01/21	195.7KB	Share
OIL	Appointment of Taiwan Distributor	PRICE SENSITIVE	16/12/20	198.48KB	Share
OIL	OIL 2020 AGM Presentation	PRICE SENSITIVE	26/11/20	1.28MB	Share
OIL	TGA Approval for CONVIVO and Sterile Sheath In Australia	PRICE SENSITIVE	10/11/20	173.49KB	Share
OIL	OIL September 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/10/20	408.9KB	Share
OIL	US FDA Regulatory Approval update	PRICE SENSITIVE	09/10/20	203.17KB	Share
OIL	OptiScan Capital Raising	PRICE SENSITIVE	25/09/20	227.65KB	Share
OIL	Optiscan Capital Raising	PRICE SENSITIVE	22/09/20	187.36KB	Share
OIL	Trading Halt	PRICE SENSITIVE	21/09/20	220.64KB	Share
OIL	Pause in Trading	PRICE SENSITIVE	21/09/20	116.4KB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	08/09/20	292.87KB	Share
OIL	Appendix 4E and 2020 Annual Report	PRICE SENSITIVE	31/08/20	1.29MB	Share
OIL	New North American & Expanded Asia Pacific Distribution	PRICE SENSITIVE	28/08/20	176.02KB	Share
OIL	OIL June 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	31/07/20	413.75KB	Share
OIL	2 X China Tender Success for FIVE2 (ViewnVivo)	PRICE SENSITIVE	28/07/20	178.61KB	Share
OIL	Government grant to support Melbourne Dental School Trial	PRICE SENSITIVE	20/07/20	227.17KB	Share
OIL	Achievement of Final Milestone in Carl Zeiss Agreement	PRICE SENSITIVE	04/05/20	200.1KB	Share
OIL	OIL March 2020 Quarterly Report and Appendix 4C	PRICE SENSITIVE	30/04/20	403.99KB	Share
OIL	Response to ASX Price Query	PRICE SENSITIVE	07/04/20	794.58KB	Share
OIL	Pause in Trading	PRICE SENSITIVE	07/04/20	115.4KB	Share
OIL	Corporate Update	PRICE SENSITIVE	20/03/20	218.19KB	Share
OIL	Appendix 4D and Financial Statements - 31 December 2019	PRICE SENSITIVE	28/02/20	819.49KB	Share
OIL	Corporate Update - January 2020	PRICE SENSITIVE	31/01/20	200.44KB	Share
OIL	Appointment of Second China Distributor	PRICE SENSITIVE	05/12/19	200.25KB	Share
OIL	2019 AGM Presentation	PRICE SENSITIVE	28/11/19	2.03MB	Share
OIL	Optiscan Market Update	PRICE SENSITIVE	25/11/19	204.25KB	Share
OIL	OIL initiates FDA feedback for Oral Cancer 510(k) submission	PRICE SENSITIVE	04/11/19	205.09KB	Share

OIL Quarterly Activities/Appendix 4C Cash Flow Report
31/07/25	PRICE SENSITIVE	351.25KB	Share
OIL Optiscan Initiates Breast Cancer Study in Melbourne
30/06/25	PRICE SENSITIVE	209.68KB	Share
OIL Optiscan Signs Agreement with Long Grove Pharmaceuticals
23/06/25	PRICE SENSITIVE	181.14KB	Share
OIL Optiscan Reveals InSpecta Device for Veterinary Medicine
10/06/25	PRICE SENSITIVE	214.9KB	Share
OIL Optiscan Completes Cloud-based Telepathology Software MVP
27/05/25	PRICE SENSITIVE	148.85KB	Share
OIL Robotic Surgery Collaboration with Mayo Clinic Progresses
13/05/25	PRICE SENSITIVE	161.82KB	Share
OIL Quarterly Activities/Appendix 4C Cash Flow Report
30/04/25	PRICE SENSITIVE	458.42KB	Share
OIL Appendix 4D
27/02/25	PRICE SENSITIVE	138.81KB	Share
OIL Optiscan Reveals InForm Imaging Device for Pathology
19/02/25	PRICE SENSITIVE	211.17KB	Share
OIL Optiscan Initiates GI Study in Germany with First Prototype
03/02/25	PRICE SENSITIVE	99.68KB	Share
OIL OIL December 2024 Quarterly Report and Appendix 4C
31/01/25	PRICE SENSITIVE	280.77KB	Share
OIL Optiscan receives $1.775m R&D Tax Refund
31/01/25	PRICE SENSITIVE	68KB	Share
OIL OIL Managing Director's Presentation & Chair's Address
21/11/24	PRICE SENSITIVE	2.72MB	Share
OIL Optiscan Signs Research Agreement with Minnesota Vet College
18/11/24	PRICE SENSITIVE	77.16KB	Share
OIL Optiscan Signs Agreement with Monash to Progress GI Scope
04/11/24	PRICE SENSITIVE	77.76KB	Share
OIL OIL September 2024 Quarterly Report and Appendix 4C
31/10/24	PRICE SENSITIVE	279.3KB	Share
OIL Appendix 4E Preliminary Final Report
30/08/24	PRICE SENSITIVE	89.32KB	Share
OIL Optiscan Signs MOU with University of Minnesota
19/08/24	PRICE SENSITIVE	102.17KB	Share
OIL OIL June 2024 Quarterly Report and Appendix 4C
31/07/24	PRICE SENSITIVE	316.61KB	Share
OIL Optiscan Delivers Major Milestone in Telepathology Platform
29/07/24	PRICE SENSITIVE	73.64KB	Share
OIL Optiscan Receives Ethical Clearance for Breast Cancer Study
15/07/24	PRICE SENSITIVE	401.21KB	Share
OIL Optiscan 2024 Roadshow Presentation
01/07/24	PRICE SENSITIVE	2.44MB	Share
OIL Optiscan Reveals InVue Imaging Device for Precision Surgery
04/06/24	PRICE SENSITIVE	172.87KB	Share
OIL Optiscan Webinar Investor Presentation
16/05/24	PRICE SENSITIVE	1.95MB	Share
OIL Optiscan Signs Know-How Agreement with Mayo Clinic
13/05/24	PRICE SENSITIVE	126.86KB	Share
OIL OIL March 2024 Quarterly Report and Appendix 4C
30/04/24	PRICE SENSITIVE	277.05KB	Share
OIL Optiscan appoints US Clinical & Regulatory Heads
02/04/24	PRICE SENSITIVE	114.29KB	Share
OIL OIL Appendix 4D and 31 December 2023 Half-year report
23/02/24	PRICE SENSITIVE	1.6MB	Share
OIL Optiscan receives $3 million CRC-P Industry Grant
13/02/24	PRICE SENSITIVE	114.39KB	Share
OIL OIL December 2023 Quarterly Report and Appendix 4C
31/01/24	PRICE SENSITIVE	324.61KB	Share
OIL OIL Managing Director's Presentation & Chair's Address
23/11/23	PRICE SENSITIVE	2.88MB	Share
OIL Response to ASX Price Query
14/11/23	PRICE SENSITIVE	223.26KB	Share
OIL OIL September 2023 Quarterly Report and Appendix 4C
31/10/23	PRICE SENSITIVE	323.62KB	Share
OIL Optiscan Correlates with Histology in Breast Study
19/09/23	PRICE SENSITIVE	102.36KB	Share
OIL OIL Appendix 4E and June 2023 Annual Report
31/08/23	PRICE SENSITIVE	1.69MB	Share
OIL Optiscan Achieves Telepathology Milestone
15/08/23	PRICE SENSITIVE	106.06KB	Share
OIL OIL June 2023 Quarterly Report and Appendix 4C
28/07/23	PRICE SENSITIVE	326.14KB	Share
OIL Entitlement Offer Results and Shortfall Announcement
12/07/23	PRICE SENSITIVE	91.36KB	Share
OIL Optiscan Entitlement Issue Prospectus
30/05/23	PRICE SENSITIVE	636.42KB	Share
OIL Optiscan Launches Entitlement Offer to Raise $16.7M
30/05/23	PRICE SENSITIVE	134.45KB	Share
OIL Trading Halt
26/05/23	PRICE SENSITIVE	183.4KB	Share
OIL OIL March 2023 Quarterly Report and Appendix 4C
28/04/23	PRICE SENSITIVE	293.18KB	Share
OIL Optiscan Platform Highly Accurate for Oral Cancer Diagnosis
14/03/23	PRICE SENSITIVE	108.11KB	Share
OIL Optiscan Intends to pursue De Novo Pathway for InVivage
02/03/23	PRICE SENSITIVE	97.89KB	Share
OIL OIL Appendix 4D and 31 December 2022 Half-year report
27/02/23	PRICE SENSITIVE	1.65MB	Share
OIL Optiscan partners with Prolucid to develop AI Algorithms
30/01/23	PRICE SENSITIVE	99.21KB	Share
OIL OIL December 2022 Quarterly Report and Appendix 4C
27/01/23	PRICE SENSITIVE	402.35KB	Share
OIL Optiscan Managing Director 2022 AGM Presentation
24/11/22	PRICE SENSITIVE	6.77MB	Share
OIL OIL September 2022 Quarterly Report and Appendix 4C
31/10/22	PRICE SENSITIVE	407.08KB	Share
OIL Optiscan Imaging Acquires Intellectual Property
25/10/22	PRICE SENSITIVE	195.68KB	Share
OIL Appendix 4E and 2022 Annual Report
31/08/22	PRICE SENSITIVE	1.08MB	Share
OIL Optiscan Submits FDA 510(k) Application for InVivage Device
22/08/22	PRICE SENSITIVE	189.3KB	Share
OIL OIL June 2022 Quarterly Report and Appendix 4C
29/07/22	PRICE SENSITIVE	422.39KB	Share
OIL Strategic Distribution Partnership - Additional Information
28/06/22	PRICE SENSITIVE	183.5KB	Share
OIL Optiscan announces Strategic Distribution Partner for China
27/06/22	PRICE SENSITIVE	187.04KB	Share
OIL OIL March 2022 Quarterly Report and Appendix 4C
29/04/22	PRICE SENSITIVE	388.88KB	Share
OIL Appendix 4D and 31 December 2021 Half-year report
24/02/22	PRICE SENSITIVE	606.54KB	Share
OIL OIL December 2021 Quarterly Report and Appendix 4C
31/01/22	PRICE SENSITIVE	398.39KB	Share
OIL 2021 AGM Chairman's Address and MD Presentation
20/01/22	PRICE SENSITIVE	3.32MB	Share
OIL Change of Managing Director
13/12/21	PRICE SENSITIVE	202.2KB	Share
OIL Completion of imaging for Melbourne Breast cancer trial
12/11/21	PRICE SENSITIVE	162.56KB	Share
OIL OIL September 2021 Quarterly Report and Appendix 4C
27/10/21	PRICE SENSITIVE	398.13KB	Share
OIL Receipt of R&D Tax Incentive Rebate
25/10/21	PRICE SENSITIVE	142.02KB	Share
OIL OIL FY21 Annual Results Presentation
30/08/21	PRICE SENSITIVE	1MB	Share
OIL Appendix 4E and 2021 Annual Report
30/08/21	PRICE SENSITIVE	1.35MB	Share
OIL OIL June 2021 Quarterly Report and Appendix 4C
30/07/21	PRICE SENSITIVE	417.64KB	Share
OIL Update on seeking United States FDA approval & market entry
01/06/21	PRICE SENSITIVE	160.88KB	Share
OIL OIL March 2021 Quarterly Report and Appendix 4C
29/04/21	PRICE SENSITIVE	395.38KB	Share
OIL Appointment of New Non-executive Chair
19/04/21	PRICE SENSITIVE	208.78KB	Share
OIL Appendix 4D and Financial Statements - 31 December 2020
25/02/21	PRICE SENSITIVE	1.13MB	Share
OIL OIL breast cancer study to commence next stage - revised
08/02/21	PRICE SENSITIVE	199.92KB	Share
OIL Optiscan breast cancer study to commence next stage
08/02/21	PRICE SENSITIVE	199.91KB	Share
OIL OIL December 2020 Quarterly Report and Appendix 4C
29/01/21	PRICE SENSITIVE	408.83KB	Share
OIL Carl Zeiss Meditec AG Product Orders
13/01/21	PRICE SENSITIVE	195.7KB	Share
OIL Appointment of Taiwan Distributor
16/12/20	PRICE SENSITIVE	198.48KB	Share
OIL OIL 2020 AGM Presentation
26/11/20	PRICE SENSITIVE	1.28MB	Share
OIL TGA Approval for CONVIVO and Sterile Sheath In Australia
10/11/20	PRICE SENSITIVE	173.49KB	Share
OIL OIL September 2020 Quarterly Report and Appendix 4C
30/10/20	PRICE SENSITIVE	408.9KB	Share
OIL US FDA Regulatory Approval update
09/10/20	PRICE SENSITIVE	203.17KB	Share
OIL OptiScan Capital Raising
25/09/20	PRICE SENSITIVE	227.65KB	Share
OIL Optiscan Capital Raising
22/09/20	PRICE SENSITIVE	187.36KB	Share
OIL Trading Halt
21/09/20	PRICE SENSITIVE	220.64KB	Share
OIL Pause in Trading
21/09/20	PRICE SENSITIVE	116.4KB	Share
OIL Response to ASX Price Query
08/09/20	PRICE SENSITIVE	292.87KB	Share
OIL Appendix 4E and 2020 Annual Report
31/08/20	PRICE SENSITIVE	1.29MB	Share
OIL New North American & Expanded Asia Pacific Distribution
28/08/20	PRICE SENSITIVE	176.02KB	Share
OIL OIL June 2020 Quarterly Report and Appendix 4C
31/07/20	PRICE SENSITIVE	413.75KB	Share
OIL 2 X China Tender Success for FIVE2 (ViewnVivo)
28/07/20	PRICE SENSITIVE	178.61KB	Share
OIL Government grant to support Melbourne Dental School Trial
20/07/20	PRICE SENSITIVE	227.17KB	Share
OIL Achievement of Final Milestone in Carl Zeiss Agreement
04/05/20	PRICE SENSITIVE	200.1KB	Share
OIL OIL March 2020 Quarterly Report and Appendix 4C
30/04/20	PRICE SENSITIVE	403.99KB	Share
OIL Response to ASX Price Query
07/04/20	PRICE SENSITIVE	794.58KB	Share
OIL Pause in Trading
07/04/20	PRICE SENSITIVE	115.4KB	Share
OIL Corporate Update
20/03/20	PRICE SENSITIVE	218.19KB	Share
OIL Appendix 4D and Financial Statements - 31 December 2019
28/02/20	PRICE SENSITIVE	819.49KB	Share
OIL Corporate Update - January 2020
31/01/20	PRICE SENSITIVE	200.44KB	Share
OIL Appointment of Second China Distributor
05/12/19	PRICE SENSITIVE	200.25KB	Share
OIL 2019 AGM Presentation
28/11/19	PRICE SENSITIVE	2.03MB	Share
OIL Optiscan Market Update
25/11/19	PRICE SENSITIVE	204.25KB	Share
OIL OIL initiates FDA feedback for Oral Cancer 510(k) submission
04/11/19	PRICE SENSITIVE	205.09KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 9.2¢		Change -0.003(3.16%)		Mkt cap ! $76.85M

Open	High	Low	Value	Volume
9.5¢	9.5¢	9.2¢	$5.162K	56.10K

Buyers (Bids)

No.	Vol.	Price($)
2	6370	9.3¢

Sellers (Offers)

Price($)	Vol.	No.
9.4¢	150000	1

View Market Depth

No.	Vol.	Price($)
2	6370	0.093
1	18028	0.092
2	11209	0.090
2	31764	0.085
2	26345	0.081

Price($)	Vol.	No.
0.094	150000	1
0.095	93793	1
0.100	796343	4
0.110	22212	1
0.115	5840	1

Last trade - 10.08am 11/08/2025 (20 minute delay)

OIL (ASX) Chart

OPTISCAN IMAGING LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories